The largest community of pharma leaders

NeuroPace Announces Michael Favet as CEO

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced the appointment of Michael Favet as Chief Executive Officer. Frank Fischer, after 20 years serving as CEO, continues with NeuroPace as Chairman of the Board of Directors. Mr. Favet has served on the NeuroPace board since 2016, and has been the acting Chief Commercial Officer since 2018. Mr. Favet has twenty years of experience in senior management positions at a variety of…

Recent Articles